Nicolas C. Issa

2.2k total citations
57 papers, 978 citations indexed

About

Nicolas C. Issa is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Nicolas C. Issa has authored 57 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 21 papers in Infectious Diseases and 11 papers in Oncology. Recurrent topics in Nicolas C. Issa's work include Cytomegalovirus and herpesvirus research (17 papers), Antifungal resistance and susceptibility (10 papers) and Herpesvirus Infections and Treatments (9 papers). Nicolas C. Issa is often cited by papers focused on Cytomegalovirus and herpesvirus research (17 papers), Antifungal resistance and susceptibility (10 papers) and Herpesvirus Infections and Treatments (9 papers). Nicolas C. Issa collaborates with scholars based in United States, Canada and Saudi Arabia. Nicolas C. Issa's co-authors include Jay A. Fishman, Lindsey R. Baden, Francisco M. Marty, Sophia Koo, Robin Patel, Robert J. Soiffer, Matthew P. Cheng, Joseph H. Antin, Alyssa R. Letourneau and Vincent T. Ho and has published in prestigious journals such as Blood, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Nicolas C. Issa

53 papers receiving 962 citations

Peers

Nicolas C. Issa
Joanna Schaenman United States
Stanley I. Martin United States
Dino Sgarabotto Italy
M. Green United States
Vincent Aubert Switzerland
Petr Hubáček Czechia
Raisa Loginov Finland
Carmen Díaz‐Pedroche Spain
Garrett Nichols United States
Maha Assi United States
Joanna Schaenman United States
Nicolas C. Issa
Citations per year, relative to Nicolas C. Issa Nicolas C. Issa (= 1×) peers Joanna Schaenman

Countries citing papers authored by Nicolas C. Issa

Since Specialization
Citations

This map shows the geographic impact of Nicolas C. Issa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas C. Issa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas C. Issa more than expected).

Fields of papers citing papers by Nicolas C. Issa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas C. Issa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas C. Issa. The network helps show where Nicolas C. Issa may publish in the future.

Co-authorship network of co-authors of Nicolas C. Issa

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas C. Issa. A scholar is included among the top collaborators of Nicolas C. Issa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas C. Issa. Nicolas C. Issa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherman, Amy C, Simon D. van Haren, Ella Borberg, et al.. (2024). Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series. Vaccine. 42(22). 126054–126054. 3 indexed citations
2.
Kakoullis, Loukas, Andy Kim, Bridget Yates, et al.. (2023). 2707. Complications of Babesiosis in Immunocompromised and Asplenic/Hyposplenic Patients. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
3.
Little, Jessica S, Sonya Davey, Guohai Zhou, et al.. (2023). Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients. Transplantation and Cellular Therapy. 29(6). 398.e1–398.e5. 11 indexed citations
4.
Little, Jessica S, Rémy Duléry, Roman M. Shapiro, et al.. (2023). Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft. Transplantation and Cellular Therapy. 30(2). 233.e1–233.e14. 5 indexed citations
5.
Sherman, Amy C, Chi‐An Cheng, Zoe Swank, et al.. (2023). Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 29(5). 337.e1–337.e5. 5 indexed citations
6.
7.
Adams, Gordon, et al.. (2023). Babesia microti Variant With Multiple Resistance Mutations Detected in an Immunocompromised Patient Receiving Atovaquone Prophylaxis. Open Forum Infectious Diseases. 10(3). ofad097–ofad097. 7 indexed citations
8.
Little, Jessica S, Roman M. Shapiro, David W. Kubiak, et al.. (2022). Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome. Transplantation and Cellular Therapy. 28(8). 508.e1–508.e8. 8 indexed citations
9.
Chen, Evan C., Yiwen Liu, Eric S. Winer, et al.. (2022). Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax. Leukemia & lymphoma. 63(8). 1934–1941. 21 indexed citations
10.
Issa, Nicolas C., et al.. (2021). Risk constellations, viral infections, and prophylaxis in uterine transplantation. Current Opinion in Organ Transplantation. 26(6). 646–653. 2 indexed citations
11.
Baumrin, Emily, Matthew P. Cheng, Sanjat Kanjilal, et al.. (2019). Severe Herpes Zoster Requiring Intravenous Antiviral Treatment in Allogeneic Hematopoietic Cell Transplantation Recipients on Standard Acyclovir Prophylaxis. Biology of Blood and Marrow Transplantation. 25(8). 1642–1647. 10 indexed citations
12.
Letourneau, Alyssa R., Nicolas C. Issa, & Lindsey R. Baden. (2014). Pneumonia in the immunocompromised host. Current Opinion in Pulmonary Medicine. 20(3). 272–279. 29 indexed citations
13.
Galar, Alicia, David W. Kubiak, Steve Boukedes, et al.. (2014). Serologic Response to Hepatitis B Vaccination Among Lung Transplantation Candidates. Transplantation. 98(6). 676–679. 6 indexed citations
14.
Issa, Nicolas C., Francisco M. Marty, Alka Patel, et al.. (2013). Postoperative Antibacterial Prophylaxis for the Prevention of Infectious Complications Associated With Tube Thoracostomy in Patients Undergoing Elective General Thoracic Surgery. JAMA Surgery. 148(5). 440–440. 26 indexed citations
15.
Hammond, Sarah P., Sophia Koo, Nicolas C. Issa, et al.. (2012). Infections Following Facial Composite Tissue Allotransplantation—Single Center Experience and Review of the Literature. American Journal of Transplantation. 13(3). 770–779. 36 indexed citations
16.
Issa, Nicolas C. & Lindsey R. Baden. (2012). Current Issues in Vaccines for Adult Patients With Hematologic Malignancies. Journal of the National Comprehensive Cancer Network. 10(11). 1447–1454. 14 indexed citations
17.
Alsan, Marcella, Nicolas C. Issa, Sarah P. Hammond, et al.. (2011). Candida albicans Cervical Lymphadenitis in Patients Who Have Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 11(4). 375–377. 1 indexed citations
18.
Issa, Nicolas C., et al.. (2009). Infectious Complications of Antilymphocyte Therapies in Solid Organ Transplantation. Clinical Infectious Diseases. 48(6). 772–786. 140 indexed citations
19.
Issa, Nicolas C., Mark S. Rouse, Kerryl E. Piper, et al.. (2003). In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria. Diagnostic Microbiology and Infectious Disease. 48(1). 73–75. 36 indexed citations
20.
Issa, Nicolas C. & Robin Patel. (2002). Potential for expansion of the donor pool using liver allografts from donors with bacterial meningitis. Liver Transplantation. 8(10). 977–979. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanna Schaenman Breakdown of academic impact, for papers by Stanley I. Martin Breakdown of academic impact, for papers by Dino Sgarabotto Breakdown of academic impact, for papers by M. Green Breakdown of academic impact, for papers by Vincent Aubert Breakdown of academic impact, for papers by Petr Hubáček Breakdown of academic impact, for papers by Raisa Loginov Breakdown of academic impact, for papers by Carmen Díaz‐Pedroche Breakdown of academic impact, for papers by Garrett Nichols Breakdown of academic impact, for papers by Maha Assi
Rankless by CCL
2026